Update: 28.05.2024
Last week: 20 week 2024 (13.05.2024 - 19.05.2024)
Last full month: April 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 6 777 | -3.4% | 10.4% | -1.8 | 14 898 358 | -3.2% | 8.6% | -1.6 | 13.5% |
| MoM | 36 442 | 6.8% | 11.5% | 1 | 80 510 850 | 4.8% | 9.7% | 0.8 | -2.7% |
| YTD | 144 700 | 21.4% | 11.1% | 2.4 | 322 846 607 | 49.5% | 9.5% | 2.2 | -5.0% |
| MAT | 366 319 | 31.0% | 10.0% | 1.8 | 763 689 358 | 49.3% | 8.5% | 1.5 | 7.0% |
| BRAINMAX | |||||||||
| WoW | 1 032 | 16.6% | 100.0% | 0 | 3 780 266 | 14.9% | 100.0% | 0 | 16.6% |
| MoM | 5 008 | 6.7% | 100.0% | 0 | 17 994 700 | 5.5% | 100.0% | 0 | 17.9% |
| YTD | 20 429 | 43.4% | 100.0% | 0 | 73 798 827 | 53.5% | 100.0% | 0 | 43.4% |
| MAT | 52 836 | 116.3% | 100.0% | NA | 186 709 732 | 130.9% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 19 276 | 13.3% | 43.7% | -1.8 | 59 571 595 | 12.8% | 34.7% | -2.2 | 17.8% |
| MoM | 79 648 | -0.5% | 45.8% | 1 | 250 870 960 | -0.3% | 37.3% | 1.2 | -2.7% |
| YTD | 342 096 | -1.3% | 44.5% | 1.4 | 1 086 473 817 | 3.4% | 36.3% | -2.8 | -4.4% |
| MAT | 864 379 | 13.1% | 45.5% | 1.5 | 2 727 317 849 | 21.4% | 38.5% | -0.5 | 9.3% |
| MIGRENIUM | |||||||||
| WoW | 11 082 | 2.5% | 0.5% | 0 | 3 633 028 | 2.7% | 0.7% | 0 | 4.3% |
| MoM | 61 140 | 15.8% | 0.6% | 0.1 | 19 318 134 | 20.2% | 0.9% | 0.2 | -6.0% |
| YTD | 246 474 | 1.4% | 0.6% | -0.1 | 73 277 950 | 67.2% | 0.7% | 0.2 | 16.3% |
| MAT | 644 981 | 6.6% | 0.5% | -0.1 | 152 126 006 | 38.4% | 0.6% | 0 | 17.0% |
| MODELAX-N | |||||||||
| WoW | 26 380 | 0.3% | 20.7% | -0.7 | 11 834 475 | 0.8% | 13.8% | -0.3 | 3.6% |
| MoM | 137 404 | -16.6% | 24.9% | -2.5 | 59 188 675 | -14.0% | 16.3% | -1.2 | -8.3% |
| YTD | 621 992 | 49.8% | 23.6% | 5.4 | 259 775 295 | 99.2% | 14.9% | 4.6 | 15.7% |
| MAT | 1 374 620 | 91.9% | 20.7% | 7.4 | 512 155 744 | 120.7% | 12.3% | 4.6 | 23.7% |
| REDUXIN | |||||||||
| WoW | 15 058 | 22.8% | 34.1% | 1.4 | 82 005 102 | 25.6% | 47.8% | 2.2 | 17.8% |
| MoM | 56 729 | -3.8% | 32.6% | -0.4 | 306 452 225 | -5.6% | 45.6% | -1.1 | -2.7% |
| YTD | 254 589 | -7.6% | 33.1% | -1.2 | 1 381 209 934 | 21.3% | 46.2% | 3.8 | -4.4% |
| MAT | 616 759 | 1.5% | 32.5% | -2.5 | 3 115 406 741 | 24.1% | 43.9% | 0.4 | 9.3% |
| REDUXIN FORTE | |||||||||
| WoW | 3 801 | 22.5% | 8.6% | 0.3 | 16 422 751 | 19.8% | 9.6% | 0 | 17.8% |
| MoM | 15 157 | -2.0% | 8.7% | 0.1 | 64 576 943 | -3.1% | 9.6% | 0 | -2.7% |
| YTD | 66 747 | 4.9% | 8.7% | 0.8 | 290 893 665 | 22.4% | 9.7% | 0.9 | -4.4% |
| MAT | 169 113 | 25.6% | 8.9% | 1.2 | 706 674 631 | 38.7% | 10.0% | 1.1 | 9.3% |
| SALVISAR | |||||||||
| WoW | 12 312 | 0.5% | 1.5% | -0.1 | 5 208 426 | 1.6% | 1.4% | -0.1 | 9.9% |
| MoM | 59 234 | 14.4% | 1.7% | 0.2 | 24 423 069 | 19.0% | 1.6% | 0.2 | 1.1% |
| YTD | 213 097 | -0.1% | 1.4% | -0.1 | 83 744 138 | 22.0% | 1.2% | 0 | 4.0% |
| MAT | 498 283 | -15.1% | 1.2% | -0.3 | 178 826 871 | -10.1% | 1.0% | -0.3 | 7.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 144 700 | 21.4% | 11.1% | 2.4 | 322 846 607 | 49.5% | 9.5% | 2.2 | -5.0% |
| BRAINMAX | 20 429 | 43.4% | 100.0% | 0 | 73 798 827 | 53.5% | 100.0% | 0 | 43.4% |
| GOLDLINE PLUS | 342 096 | -1.3% | 44.5% | 1.4 | 1 086 473 817 | 3.4% | 36.3% | -2.8 | -4.4% |
| MIGRENIUM | 246 474 | 1.4% | 0.6% | -0.1 | 73 277 950 | 67.2% | 0.7% | 0.2 | 16.3% |
| MODELAX-N | 621 992 | 49.8% | 23.6% | 5.4 | 259 775 295 | 99.2% | 14.9% | 4.6 | 15.7% |
| REDUXIN CAPS | 254 589 | -7.6% | 33.1% | -1.2 | 1 381 209 934 | 21.3% | 46.2% | 3.8 | -4.4% |
| REDUXIN FORTE | 66 747 | 4.9% | 8.7% | 0.8 | 290 893 665 | 22.4% | 9.7% | 0.9 | -4.4% |
| SALVISAR | 213 097 | -0.1% | 1.4% | -0.1 | 83 744 138 | 22.0% | 1.2% | 0 | 4.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 366 319 | 31.0% | 10.0% | 1.8 | 763 689 358 | 49.3% | 8.5% | 1.5 | 7.0% |
| BRAINMAX | 52 836 | 116.3% | 100.0% | NA | 186 709 732 | 130.9% | 100.0% | NA | NA |
| GOLDLINE PLUS | 864 379 | 13.1% | 45.5% | 1.5 | 2 727 317 849 | 21.4% | 38.5% | -0.5 | 9.3% |
| MIGRENIUM | 644 981 | 6.6% | 0.5% | -0.1 | 152 126 006 | 38.4% | 0.6% | 0 | 17.0% |
| MODELAX-N | 1 374 620 | 91.9% | 20.7% | 7.4 | 512 155 744 | 120.7% | 12.3% | 4.6 | 23.7% |
| REDUXIN CAPS | 616 759 | 1.5% | 32.5% | -2.5 | 3 115 406 741 | 24.1% | 43.9% | 0.4 | 9.3% |
| REDUXIN FORTE | 169 113 | 25.6% | 8.9% | 1.2 | 706 674 631 | 38.7% | 10.0% | 1.1 | 9.3% |
| SALVISAR | 498 283 | -15.1% | 1.2% | -0.3 | 178 826 871 | -10.1% | 1.0% | -0.3 | 7.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 6 777 | -3.4% | 10.4% | -1.8 | 14 898 358 | -3.2% | 8.6% | -1.6 | 13.5% |
| BRAINMAX | 1 032 | 16.6% | 100.0% | 0 | 3 780 266 | 14.9% | 100.0% | 0 | 16.6% |
| GOLDLINE PLUS | 19 276 | 13.3% | 43.7% | -1.8 | 59 571 595 | 12.8% | 34.7% | -2.2 | 17.8% |
| MIGRENIUM | 11 082 | 2.5% | 0.5% | 0 | 3 633 028 | 2.7% | 0.7% | 0 | 4.3% |
| MODELAX-N | 26 380 | 0.3% | 20.7% | -0.7 | 11 834 475 | 0.8% | 13.8% | -0.3 | 3.6% |
| REDUXIN CAPS | 15 058 | 22.8% | 34.1% | 1.4 | 82 005 102 | 25.6% | 47.8% | 2.2 | 17.8% |
| REDUXIN FORTE | 3 801 | 22.5% | 8.6% | 0.3 | 16 422 751 | 19.8% | 9.6% | 0 | 17.8% |
| SALVISAR | 12 312 | 0.5% | 1.5% | -0.1 | 5 208 426 | 1.6% | 1.4% | -0.1 | 9.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 36 442 | 6.8% | 11.5% | 1 | 80 510 850 | 4.8% | 9.7% | 0.8 | -2.7% |
| BRAINMAX | 5 008 | 6.7% | 100.0% | 0 | 17 994 700 | 5.5% | 100.0% | 0 | 17.9% |
| GOLDLINE PLUS | 79 648 | -0.5% | 45.8% | 1 | 250 870 960 | -0.3% | 37.3% | 1.2 | -2.7% |
| MIGRENIUM | 61 140 | 15.8% | 0.6% | 0.1 | 19 318 134 | 20.2% | 0.9% | 0.2 | -6.0% |
| MODELAX-N | 137 404 | -16.6% | 24.9% | -2.5 | 59 188 675 | -14.0% | 16.3% | -1.2 | -8.3% |
| REDUXIN CAPS | 56 729 | -3.8% | 32.6% | -0.4 | 306 452 225 | -5.6% | 45.6% | -1.1 | -2.7% |
| REDUXIN FORTE | 15 157 | -2.0% | 8.7% | 0.1 | 64 576 943 | -3.1% | 9.6% | 0 | -2.7% |
| SALVISAR | 59 234 | 14.4% | 1.7% | 0.2 | 24 423 069 | 19.0% | 1.6% | 0.2 | 1.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs